Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Dishman Carbogen Amcis Ltd.

Dishman Carbogen Amc

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
11 05 2021 Audited Results
16 06 2021 Employees Stock Option Plan(Cancelled)
12 08 2021 Quarterly Results
28 10 2021 Quarterly Results
03 02 2022 Quarterly Results
10 05 2022 Audited Results
09 08 2022 Quarterly Results
11 11 2022 Quarterly Results
17 01 2023 Inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, in one or more tranche or tranches, subject to such regulatory or statutory approvals as may be required.
10 02 2023 Quarterly Results
10 03 2023 Inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, subject to such regulatory or statutory approvals as may be required
23 05 2023 Audited Results
09 08 2023 Quarterly Results
08 11 2023 Quarterly Results
14 02 2024 Quarterly Results
13 11 2024 Quarterly Results
12 02 2025 Quarterly Results
12 03 2025 Inter alia, to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures, by way of private placement, subject to such regulatory or statutory approvals as may be required.
21 05 2025 Audited Results
12 08 2025 Increase in Authorised Capital & Fund raising & Quarterly Results
04 11 2025 Quarterly Results

News

08-OCT-2025

Dishman Carbogen Amcis’ arm partners with Celonic Group

The partnership is to offer a fully integrated Antibody-Drug Conjugate (ADC) development and manufacturing solution

11:00 AM
28-AUG-2025

Dishman Carbogen Amcis receives EIR from USFDA

The company has secured Establishment Inspection Report for its Naroda facility

12:59 PM
16-JUN-2025

USFDA completes inspection at Dishman Carbogen Amcis’ facility in Naroda

The inspection was concluded without any observation or issuance of form 483’s, confirming that no concerns were discovered during the inspection

09:48 AM
06-JUN-2025

Dishman Carbogen Amcis’ arm enters into co-investment agreement with Japanese customer

The investment will support the production of a drug linker for a commercial antibody-drug conjugate, enabling Carbogen Amcis to meet rising global demand

03:47 PM
22-APR-2025

Dishman Carbogen Amcis’ arm gets drug manufacturing license from NMPA for Shanghai facility

This milestone marks a pivotal step in Carbogen Amcis’ expansion in China and reinforces its commitment to customers in the region

11:52 AM
26-MAR-2025

Dishman Carbogen Amcis raises Rs 50 crore through NCDs

The Management Committee of Board of Directors has at its meeting held on March 26, 2025 approved allotment of the same

03:51 PM
20-MAR-2025

Dishman Carbogen Amcis’ arm receives Certificate of GMP Compliance form ANSM

CARBOGEN AMCIS SAS has received the certificate for its Saint-Beauzire Site in France

01:00 PM
10-JAN-2025

Dishman Carbogen Amcis’ arm completes Swissmedic inspection of Vionnaz facility

It reinforces CARBOGEN AMCIS’s strong history of compliance with Swissmedic requirements

02:58 PM
16-FEB-2023

Dishman Carbogen Amcis’ arm completes USFDA’s inspection at Switzerland manufacturing site

The inspection was concluded without any major or critical observations

04:58 PM
29-SEP-2022

Dishman Carbogen Amcis’ arm completes Swissmedic inspection of facility in Switzerland

This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020

12:17 PM
Enrich money logo